ACLARION, INC. Operating Expenses
ACLARION, INC. (ACON) reported Operating Expenses of $2.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- ACLARION, INC. operating expenses for the quarter ending 2026-06-30 was $2.91M, a 66.97% increase year-over-year.
- ACLARION, INC. operating expenses for the quarter ending 2026-03-31 was $2.99M, a 101.06% increase year-over-year.
- ACLARION, INC. operating expenses for the quarter ending 2025-12-31 was $1.99M, a 11.07% increase year-over-year.
- ACLARION, INC. operating expenses for the quarter ending 2025-09-30 was $1.84M, a 42.38% increase year-over-year.
- ACLARION, INC. operating expenses for fiscal 2025 was $7.06M, a 28.96% increase from fiscal 2024.
- ACLARION, INC. operating expenses for fiscal 2024 was $5.47M, a 12.27% increase from fiscal 2023.
- ACLARION, INC. operating expenses for fiscal 2023 was $4.88M, a 12.26% decline from fiscal 2022.
- ACLARION, INC. operating expenses for fiscal 2022 was $5.56M, a 88.74% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.91M 10-Q · filed 2026-08-06 | $5.90M 10-Q · filed 2026-08-06 | $7.89M derived: sum of 3 quarters · filed 2026-08-06 | $9.73M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.99M 10-Q · filed 2026-05-13 | $4.99M derived: sum of 2 quarters · filed 2026-05-13 | $6.82M derived: sum of 3 quarters · filed 2026-05-13 | $8.56M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $3.83M derived: sum of 2 quarters · filed 2026-03-18 | $5.57M derived: sum of 3 quarters · filed 2026-08-06 | $7.06M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $1.84M 10-Q · filed 2025-11-12 | $3.58M derived: sum of 2 quarters · filed 2026-08-06 | $5.06M 10-Q · filed 2025-11-12 | $6.86M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.74M 10-Q · filed 2026-08-06 | $3.23M 10-Q · filed 2026-08-06 | $5.02M derived: sum of 3 quarters · filed 2026-08-06 | $6.31M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.49M 10-Q · filed 2026-05-13 | $3.28M derived: sum of 2 quarters · filed 2026-05-13 | $4.57M derived: sum of 3 quarters · filed 2026-05-13 | $5.70M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $3.08M derived: sum of 2 quarters · filed 2026-03-18 | $4.21M derived: sum of 3 quarters · filed 2026-03-18 | $5.47M 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $1.29M 10-Q · filed 2025-11-12 | $2.41M derived: sum of 2 quarters · filed 2025-11-12 | $3.68M 10-Q · filed 2025-11-12 | $4.80M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.12M 10-Q · filed 2025-08-14 | $2.39M 10-Q · filed 2025-08-14 | $3.51M derived: sum of 3 quarters · filed 2025-08-14 | $4.67M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.27M 10-Q · filed 2025-05-15 | $2.39M derived: sum of 2 quarters · filed 2025-05-15 | $3.55M derived: sum of 3 quarters · filed 2025-05-15 | $4.95M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $2.28M derived: sum of 2 quarters · filed 2025-04-09 | $3.69M derived: sum of 3 quarters · filed 2025-04-09 | $4.88M 10-K · filed 2025-04-09 | ||||
| 2023-09-30 | $1.16M 10-Q · filed 2024-11-14 | $2.57M derived: sum of 2 quarters · filed 2024-11-14 | $3.75M 10-Q · filed 2024-11-14 | $4.70M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.40M 10-Q · filed 2024-08-14 | $2.59M 10-Q · filed 2024-08-14 | $3.54M derived: sum of 3 quarters · filed 2024-08-14 | $5.18M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $1.19M 10-Q · filed 2024-05-15 | $2.14M derived: sum of 2 quarters · filed 2024-05-15 | $3.77M derived: sum of 3 quarters · filed 2024-05-15 | $5.98M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $947.69K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.58M derived: sum of 2 quarters · filed 2024-03-28 | $4.79M derived: sum of 3 quarters · filed 2024-03-28 | $5.56M 10-K · filed 2024-03-28 | $6.09M 10-K · filed 2023-02-27 | |||
| 2022-09-30 | $1.63M 10-Q · filed 2023-11-14 | $3.84M derived: sum of 2 quarters · filed 2023-11-14 | $4.61M 10-Q · filed 2023-11-14 | $4.76M 10-Q · filed 2022-11-14 | $5.67M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $2.21M 10-Q · filed 2023-08-25 | $2.36M 10-Q · filed 2022-08-15 | $2.97M 10-Q · filed 2023-08-25 | $3.13M 10-Q · filed 2022-08-15 | $4.04M derived: sum of 3 quarters · filed 2023-08-25 | $4.83M derived: sum of 4 quarters · filed 2023-08-25 | ||
| 2022-03-31 | $765.39K 10-Q · filed 2023-07-03 | $1.83M derived: sum of 2 quarters · filed 2023-07-03 | $2.62M derived: sum of 3 quarters · filed 2023-07-03 | $3.25M derived: sum of 4 quarters · filed 2023-07-03 | ||||
| 2021-12-31 | $1.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $1.86M derived: sum of 2 quarters · filed 2023-06-12 | $2.49M derived: sum of 3 quarters · filed 2023-06-12 | $2.94M 10-K/A · filed 2023-06-12 | ||||
| 2021-09-30 | $792.03K 10-Q · filed 2022-11-14 | $1.42M derived: sum of 2 quarters · filed 2022-11-14 | $1.88M 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | $631.94K 10-Q · filed 2022-08-15 | $1.09M 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | $455.81K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |